HealthRadio.Net - The Health Radio Network
Listen Now Archives for Health Radio Net Resouces - Health, Wellness & Fitness extra
   
    | 
Thursday, October 16 2008 2:55 am est
 
 
 

Directory

Emerging Treatments for Scleroderma

Show Date
2008-04-17
Guest(s)
Dr. Arthur Theodore, Patient Chris O'Leary and Patient Francesco Scarcella
Topic
Emerging Treatments for Scleroderma
Topic Info
Scleroderma is a chronic autoimmune disease that severely affects the skin, blood vessels, and connective tissue. While there is currently no cure for scleroderma, ongoing research efforts and new treatments are emerging, and scientists are optimistic. Join us for this webcast with expert Dr. Art Theodore, a nationally recognized physician who focuses on systemic sclerosis and interstitial lung disease. Dr. Theodore will answer your questions live, as well as discuss new treatments and experimental therapy for scleroderma.
Host
Andrew Schorr
Rate this listing
0 vote


 
 

 
 
Top Listing
1. You The Owner's Manual...
    Category: You, The Owner's Manual w/ Dr. Michael Roizen
    Created: Oct 18, 2008
2. You The Owner's Manual...
    Category: You, The Owner's Manual w/ Dr. Michael Roizen
    Created: Oct 18, 2008
3. NORTHSHORE RADIO: Life...
    Category: Melanie Cole M.S.
    Created: Oct 15, 2008
4. NORTHSHORE RADIO: ...
    Category: Melanie Cole M.S.
    Created: Oct 15, 2008
5. MISSION HOSPITAL: How...
    Category: Melanie Cole M.S.
    Created: Oct 14, 2008
Show more...
library_inner.gif

 
 

Information provided on the HealthRadio.Net programs and website are for educational and entertainment purposes only. Questions regarding your health and care should be directed to your personal health care provider. The HealthRadio.Net staff and hosts do not offer medical or nutritional advice. Comments and Advice give by the HealthRadio.Net hosts and guests are not necessarily the opinions of HealthRadio.Net.
© 2008 HealthRadio.Net. All Rights Reserved.
Terms under which this service is provided to you.
Read our privacy guidelines. Contact us.